Company: PFSA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076861
Chunk: 94

Company: Profusa, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 94
---
PROFUSA, INC. (F/K/A NORTHVIEW ACQUISITION
CORPORATION)

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS

Note 1 – Description of Organization and Business Operations

NorthView Acquisition Corporation (now known
as Profusa, Inc.) (the “Company” or “Northview”) was a blank check company incorporated in Delaware on April
19, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (“Business Combination”).

The Company had a wholly-owned subsidiary, NV
Profusa Merger Sub Inc. (“Merger Sub”), a Delaware corporation incorporated on October 13, 2022, which was formed solely
in contemplation of the Merger with Profusa (See below). In connection with the Merger, which was consummated on July 11, 2025, Merger
Sub is no longer in existence.

Business Combination

On November 7, 2022, the Company, Profusa, Inc.,
a California corporation (“Profusa”) and Merger Sub entered into a Merger Agreement and Plan of Reorganization (as the same
has been amended, supplemented or otherwise modified from time to time, the “Merger Agreement”).

On June 5, 2025 (the “Redemption Date”),
the Company received requests to redeem a total of 52,784 Public Shares (as defined below), representing 32.4% of the total Public Shares
of the Company outstanding prior to the Redemption Date. Following the redemption, 5,295,527 Public Shares were outstanding.

At the special meeting of the stockholders held
on June 9, 2025 (the “Special Meeting”), the Company’s stockholders voted to approve the proposals outlined in the
final prospectus and definitive proxy statement filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”)
on May 15, 2025 (the “Proxy Statement/Prospectus”), including, among other things, the adoption of the Merger Agreement and
approval of the transactions contemplated thereby, including the merger of Merger Sub with and into Profusa, with Profusa continuing
as the surviving corporation and as a wholly-owned subsidiary of the Company (the “Merger”), and the issuance of the Company’s
common stock as consideration there